Long-term Safety Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS

Brief description of study

The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab clinical MS study.

Clinical Study Identifier: NCT03650114

Start Over

Novartis Investigative Site

Kawagoe, Japan

2.0miles

View all locations

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up now »

Powered by